Briefing Paper on Biological and Biosimilar Medicines

By IAPO, International Alliance of Patients’ Organizations

In 2006 IAPO published a briefing paper to educate and inform patients’ organizations on the introduction of biological and biosimilar medicines.
Since 2006, there have been many developments in biological and biosimilar medicines, with biosimilar medicines coming to market in a number of countries.

This raises the need for patients’ organizations and patients to be informed as to the situation and what it means for them.

Over the coming years, more biological and biosimilar medicines will become available to patients worldwide, providing an exciting opportunity to take stock and provide new and updated information regarding these medicines to patients.

There will also be the need to explore issues such as regulation and transparency, access, patient information and support, and patient involvement in decision-making.

This Briefing Paper aims to provide patients’ organizations with up-to-date, evidence-based information on the science, technology and regulatory information relevant to biological and biosimilar medicines.

Documenti collegati: